Markets and supply
Generics and biosimilars: market outlook
How the UK generics and biosimilars markets work, who competes in them, and what drives pricing, switching and supply.
From £249
New edition
UK pharmaceutical market report 2026
The UK pharmaceutical market mapped: how it is structured, how medicines are priced and reimbursed, and where growth and pressure are coming from.
- Format
- PDF, approx. 80 pages, plus data appendix (XLSX)
- Edition
- 2026 edition
- Delivery
- Download as soon as your payment arrives
This is a digital research report. It doesn't promote or supply any medicine, and nothing in it is medical, clinical, legal or investment advice.
What's included
- Market structure: manufacturers, wholesalers, pharmacies and the NHS
- Pricing and reimbursement schemes, and how they have changed
- Branded, generic and biosimilar segments compared
- Wholesale and distribution landscape
- Trend map: emerging, growing, established and declining developments
- Data appendix (XLSX)
About this pack
Our annual market report sets out how medicines reach UK patients, from manufacturers and wholesalers to pharmacies and the NHS, and where value is created and squeezed along the way.
Figures come with their method and date, and the data appendix is supplied as a spreadsheet so you can run your own analysis.
Scope and sources
UK market, with comparison to other European markets where it helps. Published market data, company filings, regulator and NHS publications.
More markets and supply
Markets and supply
Medicines supply chain and shortages briefing
Why medicines go short, how the UK supply chain is organised, and what manufacturers, wholesalers and pharmacies are doing about it.
From £199